A detailed history of Sierra Ocean, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Sierra Ocean, LLC holds 21 shares of PCVX stock, worth $1,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Holding current value
$1,930
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$80.97 - $117.93 $1,700 - $2,476
21 New
21 $1.72 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.45B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Sierra Ocean, LLC Portfolio

Follow Sierra Ocean, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Ocean, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Ocean, LLC with notifications on news.